Aleve Ad
This article was originally published in The Tan Sheet
Executive Summary
Bayer stresses the importance of reading the label in a new AleveTV spot that broke Jan. 14. The ad depicts a daughter concerned about her mother's use of Aleve for arthritis. The mother responds: "I checked with my doctor [and] he said Aleve is fine for me. Just follow the directions on the label." The ad comes on the heels of a recently halted study that linked naproxen to an increased risk of cardiovascular events (1"The Tan Sheet" Jan. 3, 2005, p. 3)...
You may also be interested in...
Naproxen Heart Concerns Surface In Halted NIH Alzheimer’s Trial
The OTC industry is taking a wait-and-see approach regarding concerns about cardiovascular risks of naproxen (Bayer's Aleve) and other older NSAIDs rising in the wake of COX-2-related safety issues
Despite 'Remarkable' ROI On Women’s Health Investments, Money Still Lacking
Recent US government initiatives and growing investor interest are important for developing female-specific therapeutics, but funding is not yet where it should be.
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.